Replies to post #521981 on NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

Seems FDA sees it differently as the approved indication is:" Optune is intended as a treatment for adult patients (22 years of age or older) with histologically-confirmed glioblastoma multiforme (GBM)." No screening for IDH mutant type.